English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round
Oct 20, 2022 14:45 HKT
Sirnaomics to Present Latest Developments on GalAhead(TM) Therapeutic Platform at Upcoming Industry Conferences
Oct 19, 2022 13:01 HKT
AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program
Oct 18, 2022 07:00 HKT
The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval
Oct 17, 2022 11:00 HKT
EC Healthcare expects a record-high semi-annual sales volume in first half of FY23 of no less than HK$1.8 billion, Represents no less than 17% Y-o-Y increase
Oct 17, 2022 08:48 HKT
Essex Biotechnology Secures Exclusive Rights and Interests in SkQ1 for Ophthalmology from Mitotech
Oct 13, 2022 22:40 HKT
Malaysian Genomics Signs Agreement with National Institutes of Health to Explore Research Opportunities
Oct 12, 2022 13:00 HKT
Novotech India Recognised as "Best Workplaces for Women 2022" by Global Work Standards Authority
Oct 12, 2022 09:00 HKT
Olympus EU-ME3 Ultrasound Processor, Delivers Higher Resolution Images for Endoscopic Ultrasound
Oct 10, 2022 14:00 HKT
Hua Medicine's Innovative First-In-Class Glucokinase Activator (GKA) HuaTangNing Is Approved, New Type 2 Diabetes Treatment Paradigm to Begin in China
Oct 10, 2022 09:00 HKT
Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO
Oct 07, 2022 10:00 HKT
AIM Vaccine, a Major Player in the Chinese Vaccine Industry, Successfully Listed on the Main Board of SEHK
Oct 06, 2022 19:16 HKT
AIM Vaccine Announces Global Offering Results, Offer Price of HK$16.16 per H Share
Oct 05, 2022 18:55 HKT
Bio Farma secures Multi-year Purchase Contract from UNICEF for its novel Oral Polio Vaccine type 2 (nOPV2)
Oct 04, 2022 07:00 HKT
Bio Farma to Export its Polio Vaccine After Securing Purchase Contracts from UNICEF for 2022 and 2023
Sep 30, 2022 18:00 HKT
Q&M Group awards 7 Dentists with Performance Shares, 12-year Service Agreements, and a Private Placement
Sep 30, 2022 15:00 HKT
Lepu Biopharma: Puyouheng (pucotenlimab injection) obtains approval for marketing with a new indication, Breakthrough therapy designation granted by the CDE to MRG003 for the treatment of R/M NPC
Sep 29, 2022 15:40 HKT
Taiwan Stays at the Forefront of Medical Technology
Sep 29, 2022 13:00 HKT
Claudin18.2, a shining star in gastric cancer, Transcenta's TST001 stands at the global forefront
Sep 28, 2022 19:24 HKT
Avance Clinical Wins International Health Award for Biotech CRO Services
Sep 28, 2022 16:00 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: